115 related articles for article (PubMed ID: 12409668)
1. Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer.
van der Hoeven JJ; Hoekstra OS; Comans EF; Pijpers R; Boom RP; van Geldere D; Meijer S; Lammertsma AA; Teule GJ
Ann Surg; 2002 Nov; 236(5):619-24. PubMed ID: 12409668
[TBL] [Abstract][Full Text] [Related]
2. Reliability of predicting low-burden (≤ 2) positive axillary lymph nodes indicating sentinel lymph node biopsy in primary operable breast cancer - a retrospective comparative study with PET/CT and breast MRI.
Sae-Lim C; Wu WP; Chang MC; Lai HW; Chen ST; Chou CT; Liao CY; Huang HI; Chen ST; Chen DR; Hung CL
World J Surg Oncol; 2024 Jan; 22(1):12. PubMed ID: 38183069
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the axillary lymph-node metastatic burden of breast cancer by
Li Y; Han D; Shen C
BMC Cancer; 2024 Jun; 24(1):704. PubMed ID: 38849770
[TBL] [Abstract][Full Text] [Related]
4. The predictive value, sensitivity, specificity, and accuracy of PET CT in the evaluation of axillary metastases in breast cancer.
Cetindag Ö; Avsar G; Hakseven M; Deryol R; Ertekin SÇ; Karasoy D; Eroglu A; Bayar S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):10008-10015. PubMed ID: 37916371
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in acral melanoma-predominant Asian patients.
Chen KC; Chu PY; Li CY; Wang TH; Chiu YJ
J Chin Med Assoc; 2023 Nov; 86(11):975-980. PubMed ID: 37738518
[TBL] [Abstract][Full Text] [Related]
6. (18)F-FDG PET/CT with Contrast Enhancement for Evaluation of Axillary Lymph Node Involvement in T1 Breast Cancer.
Kong EJ; Chun KA; Cho IH; Lee SJ
Nucl Med Mol Imaging; 2010 Sep; 44(3):170-6. PubMed ID: 24899946
[TBL] [Abstract][Full Text] [Related]
7. Detection of Axillary Lymph Node Involvement in Early-Stage Breast Cancer: Comparison between Staging
Gupta R; Das J; Sinha S; Agarwal S; Sharma A; Ahmed R; Chanda A; Arun I; Ray S
Indian J Nucl Med; 2023; 38(3):249-254. PubMed ID: 38046972
[TBL] [Abstract][Full Text] [Related]
8. Does F-18 FDG-PET/CT Have an Additional Impact on Axillary Approach in Early-Stage Breast Cancer?
Çelik B; Boge M; Dilege E
Eur J Breast Health; 2024 Jan; 20(1):45-51. PubMed ID: 38187104
[TBL] [Abstract][Full Text] [Related]
9. Solitary Axillary Lymph Node Metastasis From Bladder Cancer Detected by FDG PET/CT.
Deng Y; Deng Y; Wang H; Xie H; Zhang W
Clin Nucl Med; 2023 Nov; 48(11):976-977. PubMed ID: 37703444
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the Mechanism of Breast Metastasis Based on Image Recognition and Ultrasound Diagnosis.
Huang Y; Zheng S; Lai B
J Healthc Eng; 2021; 2021():4452500. PubMed ID: 34671449
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of blood supply and metabolism in tumor, axillary lymph node and normal breast tissue with F-18 FDG PET/CT in breast cancer: comparison with pathological prognostic factors.
Abdulrezzak U; Akgun H; Tutus A; Kula M; Dogan S; Oz AB; Ok E
BMC Womens Health; 2024 Jan; 24(1):45. PubMed ID: 38229093
[TBL] [Abstract][Full Text] [Related]
12. Axillary Lymph Node Metastasis as the First Symptom of Colon Cancer.
Zhao W; Li P; Li Y; He Y; Yang J
Clin Nucl Med; 2023 Dec; 48(12):1117-1118. PubMed ID: 37846156
[TBL] [Abstract][Full Text] [Related]
13. Mesenteric Castleman Disease Misdiagnosed as Lymph Node Metastasis of Rectal Cancer on 18 F-FDG PET/CT.
Liu M; Zhou J; Zhu W; Huo L; Cheng W
Clin Nucl Med; 2023 Nov; 48(11):985-986. PubMed ID: 37703486
[TBL] [Abstract][Full Text] [Related]
14. Examination of iatrogenic FDG accumulation after COVID-19 vaccination.
Takahashi K; Manabe O; Shizukuishi K; Shibata H; Kawakami H; Otsuka A; Oyama-Manabe N
Ann Nucl Med; 2024 Jun; 38(6):409-417. PubMed ID: 38563890
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Diagnostic Accuracy and Impact of Preoperative Positron Emission Tomography/Computed Tomography in the Management of Early Operable Breast Cancers.
Chandra P; Ravichander SK; Babu SM; Jain D; Nath S
Indian J Nucl Med; 2020; 35(1):40-47. PubMed ID: 31949368
[TBL] [Abstract][Full Text] [Related]
16. Axillary Reverse Mapping in Clinically Node-Positive Breast Cancer Patients.
Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E; Haba Y; Takahashi T; Shioya A; Yamada S
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958475
[TBL] [Abstract][Full Text] [Related]
17. [
Kubota K; Saginoya T; Ishiwata K; Nakasato T; Munechika H
Ann Nucl Med; 2022 Apr; 36(4):340-350. PubMed ID: 35098436
[TBL] [Abstract][Full Text] [Related]
18. Increased Metabolic Activity of the Thymus and Lymph Nodes in Pediatric Oncology Patients After Coronavirus Disease 2019 Vaccination.
Luthria G; Baratto L; Adams L; Morakote W; Daldrup-Link HE
J Nucl Med; 2024 Jan; 65(1):22-24. PubMed ID: 37884331
[TBL] [Abstract][Full Text] [Related]
19. Detection of internal mammary chain infiltration in breast cancer patients by [
Garcia JR; Kauak M; Compte A; Bassa P; Llinares E; Valls E; Riera E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):73-78. PubMed ID: 37865228
[TBL] [Abstract][Full Text] [Related]
20. Exploring the value of sentinel lymph node PET/CT detection in thyroid carcinoma.
Volpe F; Piscopo L; Klain M
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):510-511. PubMed ID: 37962618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
